Fundz

Noveome Biotherapeutics, Inc. reported raising $36.2 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEOct 02, 2020

Amount Raised

$36.2 Million

$36.2 Million sold, per SEC Form D (first sale Oct 2, 2020)

Round Type

Seed

PittsburghBiotechnology

Quick answer

Noveome Biotherapeutics raised $36.2 Million in a Seed round, dated October 2, 2020. Noveome Biotherapeutics is based in Pittsburgh, Pennsylvania, United States.

How much did Noveome Biotherapeutics raise?
Noveome Biotherapeutics raised $36.2 Million in a Seed round on October 2, 2020.
What does Noveome Biotherapeutics do?
Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.
Where is Noveome Biotherapeutics based and how big is it?
Noveome Biotherapeutics is based in Pittsburgh, Pennsylvania, United States. Fundz records about 32 employees.
Who are the decision-makers at Noveome Biotherapeutics?
Fundz holds 1 contact at Noveome Biotherapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Noveome Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Rani Therapeutics raised $50M on November 16, 2020.
  • ProMIS Neurosciences raised $63K on November 16, 2020.
  • Mammogen, Inc. raised $25K (Pre-Seed) on November 16, 2020.
  • NovAccess Global Inc. raised $175K (Pre-Seed) on November 16, 2020.
  • Polaris Genomics raised $75K on November 16, 2020.
  • Aulos Bioscience, Inc. raised $15M on November 16, 2020.

Who to call at Noveome Biotherapeutics, and when

A new round usually means Noveome Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Noveome Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Noveome Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Noveome Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Noveome Biotherapeutics

Location

100 TECHNOLOGY DRIVE

Pittsburgh, Pennsylvania, United States

About

Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules directed at specific indications, Noveome’s product is a complex mixture of biomolecules that is believed to have the ability to treat a wide range of conditions and injuries. Noveome collaborates with major research centers to advance these therapeutic applications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Noveome Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at Noveome Biotherapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Noveome Biotherapeutics's next move

See what Strategic adds

Noveome Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.